Meyka Pro banner
Indivior Pharmaceuticals Inc

Stay Updated with the Latest Indivior Pharmaceuticals Inc INDV News in Real Time

Find INDV news now at Meyka AI. Stay informed with the latest Indivior Pharmaceuticals Inc stocks updates, including price news, market analysis, and expert insights.

INDVNASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$36.87
$0.91(2.41%)
U.S. Market opens in 64h 53m
Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge
📅 7 hours ago

Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge

Bitcoin surged 8% to $74,982 on Friday, August 21, 2026, extending a powerful weekly rally. The cryptocurrency has now climbed nearly 20% since Monday, fueled by a surprise US Treasury policy shift. Ethereum jumped toward $2,300, gaining roughly 18% in 24 hours, while XRP surged past $1.25.  Total crypto market capitalization reached $2.56 trillion, up…

Read more 12
Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B
📅 9 hours ago

Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B

Alphabet is spending more to keep up with demand for artificial intelligence. On July 22, 2026, the Google parent raised its 2026 capital expenditure forecast to $195 billion-$205 billion, up from $180 billion-$190 billion. The increase comes as Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. As AI demand drives higher…

Read more 12
Crypto Prices Today: Bitcoin Hits $69,551, Ethereum Gains 17.74% as Hyperliquid Surges 20.97%
📅 1 day ago

Crypto Prices Today: Bitcoin Hits $69,551, Ethereum Gains 17.74% as Hyperliquid Surges 20.97%

Crypto prices surged sharply on Thursday, August 20, 2026, breaking weeks of sideways trading. Bitcoin jumped to $69,551, gaining roughly 8% in 24 hours. Ethereum climbed 17.74% to reclaim the $2,000 level, while Hyperliquid’s HYPE token surged 20.97%. The rally followed a surprise US Treasury announcement to double its long-dated bond buyback operations.  Total crypto…

Read more 12
NVDA Stock, AMD Stock, Micron and Broadcom Gain as AI Spending Estimates Rise
📅 1 day ago

NVDA Stock, AMD Stock, Micron and Broadcom Gain as AI Spending Estimates Rise

AI spending estimates are rising again, giving semiconductor stocks a fresh boost. On August 7, 2026, Goldman Sachs estimated global AI investment could reach about $1 trillion this year, above widely cited hyperscaler spending forecasts. That outlook is supporting demand for AI chips, memory and networking hardware. As a result, NVDA stock, AMD stock, Micron…

Read more 12
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
📅 1 day ago

Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update

Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.

Read more 12
Apple iPhone 17 Pro Max Price Drops to ₹1,03,300 in India With ₹9,000 Bank Offer and Exchange Deal
📅 3 days ago

Apple iPhone 17 Pro Max Price Drops to ₹1,03,300 in India With ₹9,000 Bank Offer and Exchange Deal

The iPhone 17 Pro Max effective price has dropped sharply in India during Flipkart’s Freedom Sale 2026. The 256GB variant now lists at ₹1,41,900, down ₹8,000 from its ₹1,49,900 launch price. With eligible exchange and bank offers combined, buyers can bring the effective price down to around ₹98,300 to ₹1,03,990. How the iPhone 17 Pro…

Read more 12
Nike Stock Drops 4% to 12-Year Low Below $40 as Downgrades and Weak Sales Raise Turnaround Risks
📅 3 days ago

Nike Stock Drops 4% to 12-Year Low Below $40 as Downgrades and Weak Sales Raise Turnaround Risks

Nike stock faced fresh selling pressure on August 17, 2026, falling about 4% and moving below the $40 mark. The shares touched around $38.85, their lowest level since 2014. Weak sales, softer footwear demand, and new analyst downgrades have added to concerns about Nike’s turnaround. Investors are now watching to see whether the sportswear giant…

Read more 12
AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit
📅 4 days ago

AstraZeneca (LON: AZN) Halts Phase 3 Lung Cancer Trial After Volrustomig Fails to Show Survival Benefit

AstraZeneca has halted a late-stage trial of its lung cancer drug Volrustomig, marking a fresh pipeline setback. The FTSE 100 company said the drug, combined with chemotherapy, was unlikely to improve survival rates. An Independent Data Monitoring Committee recommended stopping the Phase 3 trial after a planned review.  This marks AstraZeneca’s second major trial halt…

Read more 12
Prichard Colón Dies at 33, 11 Years After Illegal Blows in 2015 Fight
📅 7 days ago

Prichard Colón Dies at 33, 11 Years After Illegal Blows in 2015 Fight

Prichard Colón, a promising Puerto Rican boxer, has died at 33 after spending 11 years in care following a 2015 fight injury that left him with permanent brain damage and a 221-day coma.

Read more 12

INDV News FAQ